NovoCure (NVCR) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

NovoCure (NVCR) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

NovoCure

· NVCR

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.857 B

-0.19%

General

Market Cap: $1.86B
Enterprise Value: $1.99B
Shares Outstanding: 116,450,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 76.13%
Operating Margin: -22.08%
Net Profit Margin: -21.25%
FCF Margin: -3.02%
ROA: -18.68%
ROE: -44.00%
ROIC: -26.15%
Current Ratio: 2.89
Debt-to-Equity: 0.69
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 2.65
P/FCF: —
P/B: 5.48
EV/EBITDA: -14.83

Growth

Rev 1Y: 8.28%
Rev 1Y Fwd Est: 10.75%
Rev 3Y (CAGR): 6.81%
Rev 5Y (CAGR): 5.80%
Rev 10Y (CAGR): 34.80%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $699.19M
Gross Margin: 76.13%
Operating Expenses: $686.67M
Operating Income: -$154.4M
Net Profit: -$148.57M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $93.7M
Working Capital: $417.81M
Total Assets: $795.19M
Net Debt: $139.72M
Total Liabilities: $457.1M
Total Equity: $338.09M

Cash Flow Statement (TTM)

Cash Flow from Operations: $1.49M
Cash Flow from Investing: $409.13M
Cash Flow from Financing: -$454.6M
Free Cash Flow: -$21.13M
Capital Expenditures: $22.62M